Abstract:Abstract A growing body of evidence points to a role for epidermal keratinocytes as active participants in immunologic reactions. Inasmuch as certain T cell-mediated skin diseases, such as psoriasis and atopic dermatitis, are triggered by microbial infection, we asked whether multipassaged human keratinocytes could provide the costimulatory signals necessary to induce autologous T cell proliferation in response to bacterial-derived super-antigens. On exposure to IFN-gamma, keratinocytes are induced to express HLA-DR and HLA-DQ class II MHC Ag, and the lymphocyte function-associated Ag-1 counter-receptor intercellular adhesion molecule-1 (ICAM-1). This change in keratinocyte phenotype is accompanied by the ability of these cells to support T cell proliferation induced by two different bacterial-derived superantigens, staphylococcal enterotoxins A and B. Superantigen-driven proliferation in the presence of IFN-gamma-treated keratinocytes was significantly inhibited (70-90% reduction) by mAb against the LFA-1 alpha- or beta-chain or ICAM-1. Proliferation was not inhibited by mAb against the CD28 ligands BB-1 or B7, even though these keratinocytes express BB-1. In addition to previous defined roles for class II MHC Ag, stimulation of LFA-1 on the T cells by ICAM-1 on the keratinocytes also plays an important costimulatory role in this superantigen-mediated response. The accessory cell capability of keratinocytes was not unique to superantigen driven responses as PHA, as well as anti-CD3 mAb also induced vigorous T cell proliferation when IFN-gamma-treated keratinocytes were added. However, IFN-gamma-treated keratinocytes consistently failed to provoke an allogeneic response. These data demonstrate that 1) keratinocytes can serve as accessory cells for T cell proliferation using a variety of different stimuli, 2) the LFA-1/ICAM-1 interaction plays a major role in keratinocyte-mediated costimulation, and 3) previous reports in which IFN-gamma-treated keratinocytes failed to support T cell proliferation to nominal or alloantigens, may reflect impaired Ag presentation via class II MHC molecules, rather than lack of necessary costimulatory signals. These findings highlighting the accessory cell function of keratinocytes may have implications for our understanding of the pathogenesis of immunologic disorders of the skin.

Presentation of an Endogenous MHC Class Ⅰ Restricted Autoantigen by Keratinocytes in Vitro

Construction of a MHC ClassⅠ Restricted Endogenous Antigen Presenting System in Mouse Keratinocytes

Innate Autoreactive B Cells As Antigen-Presenting Cells in the Induction of Tolerance to Conserved Keratin Polypeptide

CD4+ Th-APC with Acquired Peptide/mhc Class I and II Complexes Stimulate Type 1 Helper CD4+ and Central Memory CD8+ T Cell Responses.

Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.

Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation

A Novel Non-Contact Communication Between Human Keratinocytes and T Cells: Exosomes Derived from Keratinocytes Support Superantigen-Induced Proliferation of Resting T Cells

CD4+ Th-APC with Acquired Peptide/MHC Class I and II Complexes Stimulate Type 1 Helper CD4+ and Central Memory CD8+ T Cell Responses1

MHC cross-dressing in antigen presentation

Preliminary Insights from In Vitro Studies

High Level Expression of B7h1 Molecules by Keratinocytes Suppresses Xeno- and Allo-Reactions by Inducing Type I Regulatory T Cells

On the Site and Mode of Antigen Presentation for the Initiation of Clonal Expansion of CD8 T Cells Specific for a Natural Tumor Antigen.

Plasma Membrane Interactions That Determine Presentation of Antigens by Antigen-presenting Cells. (P5022)

MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides

Antigen Cross-Presentation in Dendric Cells: from Bench to Bedside

Alternate MHC I antigen presentation pathways allow CD8+ T-cell recognition and killing of cancer cells in the absence of ß2M or TAP

Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

Cd8(+) Cytotoxic T-Apc Stimulate Central Memoiry Cd8(+) T Cell Responses Via Acquired Peptide-Mhc Class I Complexes And Cd80 Costimulation, And Rl-2 Secretion

Redirecting Antigen Specificity to Nonspecific CD8+25+ Regular T Cells Through Antigen-Specific Peptide/mhc Complex Arming. (P1085)

Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways

CD1-mediated immune responses in mucosal tissues: molecular mechanisms underlying lipid antigen presentation system